Literature DB >> 2947237

Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.

M Maggi, S Kassis, S Malozowski, V Guardabasso, D Rodbard.   

Abstract

Neurohypophysial hormones stimulate the motility of tunica albuginea, epididymis, and vas deferens acting through oxytocin (OT) and V1 vasopressin receptors. To test the hypothesis that these hormones are involved also in the regulation of seminal vesicle physiology, we studied binding of [3H]OT and [3H] arginine vasopressin ([3H]AVP) to porcine seminal vesicle membranes. Neurohypophysial hormones bind to two different classes of sites. The first class shows low capacity (35 fmol per mg of protein) and a very high affinity (Kd less than 1 nM) for both the labeled ligands. The second class is characterized by a high capacity (2000 fmol per mg of protein) and a high affinity for AVP (Kd approximately equal to 2.5 nM), whereas OT has 160 times lower affinity. Lysine vasopressin and the V1 antagonist [1-deaminopenicillamine, 2-(O-methyl)tyrosine]Arg8-vasopressin compete with high affinity with [3H]AVP binding, whereas the V2 agonist [1-deamino,4-valine]D-Arg8-vasopressin (dVDAVP) is 110 times less potent than AVP. The OT agonist [Thr4,Gly7]OT and the OT antagonist [1(beta-mercapto-beta, beta-cyclopentamethylene propionic acid), 2-(O-ethyl)tyrosine, 8-ornithine]vasotocin failed to affect [3H]AVP binding. These findings seem to suggest that AVP interacts with the V1 vasopressin isoreceptor in porcine seminal vesicle membranes. However, AVP stimulates adenylate cyclase activity in a dose-dependent fashion with an EC50 of 14 nM, whereas OT or dVDAVP has no effect at 100 nM. Moreover, a well-characterized V1 vasopressin antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylene propionic acid),2-(O-methyl)tyrosine]Arg8-vasopressin [d(CH2)5Tyr(Me)AVP], competes with [3H]AVP binding with an IC50 of 0.17 microM. These pharmacological properties are distinct from the previously described V1 and V2 vasopressin receptors and indicate the presence of a new class of AVP receptors. Although this vasopressin isoreceptor shares some pharmacological characteristics with the V1 (pressor) isoreceptor, it has low affinity for the V1 antagonist d(CH2)5-Tyr(Me)AVP and is linked to the adenylate cyclase system. The extremely high density of AVP receptors in porcine seminal vesicles (2 pmol per mg of protein) is comparable to the density of V2 vasopressin receptors in porcine renal medulla, suggesting a physiological role for vasopressin in the seminal vesicle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947237      PMCID: PMC387025          DOI: 10.1073/pnas.83.23.8824

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A novel type of vasopressin receptor on anterior pituitary corticotrophs?

Authors:  A J Baertschi; M Friedli
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

2.  Novel ligand specificity of pituitary vasopressin receptors in the rat.

Authors:  F A Antoni
Journal:  Neuroendocrinology       Date:  1984-08       Impact factor: 4.914

Review 3.  Possible actions of gonadal oxytocin and vasopressin.

Authors:  D C Wathes
Journal:  J Reprod Fertil       Date:  1984-05

4.  Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture.

Authors:  V Giguere; F Labrie
Journal:  Endocrinology       Date:  1982-11       Impact factor: 4.736

5.  In vitro CRF activity of vasopressin analogs is not related to pressor activity.

Authors:  W Knepel; L Homolka; M Vlaskovska
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

6.  Identification and characterization of arginine vasopressin receptors in the rat testis.

Authors:  R Meidan; A J Hsueh
Journal:  Endocrinology       Date:  1985-01       Impact factor: 4.736

7.  In vitro adrenocorticotropin/beta-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity.

Authors:  W Knepel; L Homolka; M Vlaskovska; D Nutto
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

8.  Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.

Authors:  F A Antoni; M C Holmes; G B Makara; M Kárteszi; F A László
Journal:  Peptides       Date:  1984 May-Jun       Impact factor: 3.750

9.  Immunohistochemical localization of substance P, vasoactive intestinal polypeptide and gastrin-releasing peptide in vas deferens and seminal vesicle, and the effect of these and eight other neuropeptides on resting tension and neurally evoked contractile activity.

Authors:  M Stjernquist; R Håkanson; S Leander; C Owman; F Sundler; R Uddman
Journal:  Regul Pept       Date:  1983-09

10.  In vivo recording of contractile activity of pelvic urethra and seminal vesicle in rats. Effects of electrical stimulations and neurohypophysial hormones.

Authors:  J Hib; R Ponzio; O Vilar
Journal:  Andrologia       Date:  1983 Sep-Oct       Impact factor: 2.775

View more
  7 in total

1.  Mitotic activity and cell deletion in ventral prostate epithelium of intact and castrated oxytocin-treated rats.

Authors:  B Plećas; A Popović; D Jovović; M Hristić
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

Review 2.  Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

Authors:  J Peter; H Burbach; R A Adan; S J Lolait; F W van Leeuwen; E Mezey; M Palkovits; C Barberis
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

3.  Extrapituitary expression of the rat V1b vasopressin receptor gene.

Authors:  S J Lolait; A M O'Carroll; L C Mahan; C C Felder; D C Button; W S Young; E Mezey; M J Brownstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 4.  Hormonal and local regulation of uterine activity during parturition: Part I--The oxytocin system.

Authors:  M Maggi; E Baldi; T Susini
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

Review 5.  Normal male sexual function: emphasis on orgasm and ejaculation.

Authors:  Amjad Alwaal; Benjamin N Breyer; Tom F Lue
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

Review 6.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

7.  Arginine vasopressin: Direct and indirect action on metabolism.

Authors:  Mitsuhiro Yoshimura; Becky Conway-Campbell; Yoichi Ueta
Journal:  Peptides       Date:  2021-04-24       Impact factor: 3.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.